Clinical Trial Update: Combination Chemotherapy, Interferon Alfa, and Interleukin-2 in Treating Patients With Metastatic Melanoma [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating a combination of chemotherapy, interferon alfa, and interleukin-2 in patients with metastatic melanoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Interferon Alfa (interferon alfa)
• Interleukin-2 (interleukin-2)

Snippet

Sponsor: European Organisation for Research and Treatment of Cancer - EORTC | Conditions: Melanoma (Skin) | Phase 2 | Status: COMPLETED